Application of liquisolid technology for promoting the renoprotective efficacy of walnut extracts in chronic renal failure rat model

References

• Peacock M. Calcium metabolism in health and disease. Clin J Amer Soc Nephrol. 2010;5:S23–S30.
   PubMed Web of Science ®Google Scholar
• Mitch WE. Chronic kidney disease. In: Schafer AI, editor. Goldman's cecil medicine. 24 ed. Philadelphia: W.B. Saunders; 2012. p. 810–818.
   Google Scholar
• Calvo MS. Dietary considerations to prevent loss of bone and renal function. Nutrition. 2000;16:564–566.
   PubMed Web of Science ®Google Scholar
• Leon JB, Sullivan CM, Sehgal AR. The prevalence of phosphorus-containing food additives in top-selling foods in grocery stores. J Ren Nutr. 2013;23:265–270 e2
   PubMed Web of Science ®Google Scholar
• Sanchez-Gonzalez C, Ciudad CJ, Noe V, et al. Health benefits of walnut polyphenols: An exploration beyond their lipid profile. Critic Rev Food Sci Nutr. 2017;57:3373–3383.
   PubMed Web of Science ®Google Scholar
• Hayes D, Angove MJ, Tucci J, et al. Walnuts (Juglans regia) chemical composition and research in human health. Critic Rev Food Sci Nutr. 2016;56:1231–1241.
   PubMed Web of Science ®Google Scholar
• Al-Okbi SY, Mohamed DA, Hamed TE, et al. Prevention of renal dysfunction by nutraceuticals prepared from oil rich plant foods. Asian Pac J Trop Biomed. 2014;4:618–627.
   PubMedGoogle Scholar
• Del Gobbo LC, Falk MC, Feldman R, et al. Effects of tree nuts on blood lipids, apolipoproteins, and blood pressure: systematic review, meta-analysis, and dose-response of 61 controlled intervention trials. Amer J Clin Nutr. 2015;102:1347–1356.
   PubMed Web of Science ®Google Scholar
• Al-Okbi SY, Mohamed DA, Donya S, et al. Role of Bifidobacterium bifidum and plant food extracts in improving microflora and biochemical and cytogenetic parameters in adjuvant arthritis. Grasas y Aceites. 2011;62:308–320.
   Web of Science ®Google Scholar
• Paget GE, Barnes JM. Toxicity Tests. In: Laurence DR and Bacharach AL, editors. Evaluation of Drug Activities. London; New York (NY): Academic Press. 1964. p. 135–166.
   Google Scholar
• Javadzadeh Y, Siahi MR, Asnaashari S, et al. Liquisolid technique as a tool for enhancement of poorly water-soluble drugs and evaluation of their physicochemical properties. Acta Pharmaceutica. 2007;57:99–109.
   PubMedGoogle Scholar
• Javadzadeh Y, Jafari-Navimipour B, Nokhodchi A. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine). Int J Pharm. 2007;341:26–34.
   PubMed Web of Science ®Google Scholar
• Kubo H, Osawa T, Takashima K, et al. Enhancement of oral bioavailability and pharmacological effect of 1-(3,4-dimethoxyphenyl)-2,3-bis(methoxycarbonyl)-4-hydroxy-6,7,8- trimethoxynaphthalene (TA-7552), a new hypocholesterolemic agent, by micronization in co-ground mixture with D-mannitol. Biol Pharm Bull. 1996;19:741–747.
   PubMed Web of Science ®Google Scholar
• Aguiar AJ, Zelmer JE, Kinkel AW. Deaggregation behavior of a relatively insoluble substituted benzoic acid and its sodium salt. J Pharm Sci. 1967;56:1243–1252.
   PubMed Web of Science ®Google Scholar
• Craig DQM. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm. 2002;231:131–144.
   PubMed Web of Science ®Google Scholar
• Barzegar-Jalali M, Valizadeh H, Shadbad M-RS, et al. Cogrinding as an approach to enhance dissolution rate of a poorly water-soluble drug (gliclazide). Powder Technol. 2010;197:150–158.
   Web of Science ®Google Scholar
• Ruan LP, Yu BY, Fu GM, et al. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes. J Pharm Biomed Anal. 2005;38:457–464.
   PubMed Web of Science ®Google Scholar
• Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. Eur J Pharm Sci. 2000;11:S93–S98.
   PubMed Web of Science ®Google Scholar
• Barzegar-Jalali M, Dastmalchi S. Kinetic analysis of chlorpropamide dissolution from solid dispersions. Drug Dev Ind Pharm. 2007;33:63–70.
   PubMed Web of Science ®Google Scholar
• Thomas MJ, Slipper I, Walunj A, et al. Inclusion of poorly soluble drugs in highly ordered mesoporous silica nanoparticles. Int J Pharm. 2010;387:272–277.
   PubMed Web of Science ®Google Scholar
• Heikkila T, Salonen J, Tuura J, et al. Evaluation of mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 materials as API carriers for oral drug delivery. Drug Deliv. 2007;14:337–347.
   PubMed Web of Science ®Google Scholar
• Sayed E, Karavasili C, Ruparelia K, et al. Electrosprayed mesoporous particles for improved aqueous solubility of a poorly water soluble anticancer agent: in vitro and ex vivo evaluation. J Control Rel. 2018;278:142–155.
   PubMed Web of Science ®Google Scholar
• Spireas S, Sadu S, Grover R. In vitro release evaluation of hydrocortisone liquisolid tablets. J Pharm Sci. 1998;87:867–872.
   PubMed Web of Science ®Google Scholar
• Spireas S, Sadu S. Enhancement of prednisolone dissolution properties using liquisolid compacts. Int J Pharm. 1998;166:177–188.
   Web of Science ®Google Scholar
• Karmarkar AB, Gonjari ID, Hosmani AH. Liquisolid technology for dissolution rate enhancement or sustained release. Exp Opin Drug Deliv. 2010;7:1227–1234.
   PubMed Web of Science ®Google Scholar
• Nokhodchi A, Hentzschel CM, Leopold CS. Drug release from liquisolid systems: speed it up, slow it down. Exp Opin Drug Deliv. 2011;8:191–205.
   PubMed Web of Science ®Google Scholar
• Javadzadeh Y, Siahi MR, Asnaashari S, et al. An investigation of physicochemical properties of piroxicam liquisolid compacts. Pharm Develop Technol. 2007;12:337–343.
   PubMed Web of Science ®Google Scholar
• Yadav VB, Yadav AV. Improvement of Solubility and Dissolution of Indomethacin by Liquisolid and Compaction Granulation Technique. J Pharm Sci Res 2009;1:44–51.
   Google Scholar
• Khaled KA, Asiri YA, El-Sayed YM. In vivo evaluation of hydrochlorothiazide liquisolid tablets in beagle dogs. Int J Pharm. 2001;222:1–6.
   PubMed Web of Science ®Google Scholar
• El-Houssieny BM, Wahman L, Arafa NM. Bioavailability and biological activity of liquisolid compact formula of repaglinide and its effect on glucose tolerance in rabbits. Biosci Trend. 2010;4:17–24.
   PubMed Web of Science ®Google Scholar
• Singleton VL, Rossi JA. Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Amer J Enol Viticult. 1965;16:144–158.
   Google Scholar
• Patra CN, Swain S, Panigrahi KC, et al. An overview of liquisolid technology. In: Patra CN, Swain S, Bhanoji Rao ME, editors. Pharmaceutical Drug Delivery Systems and Vehicles: Boca Rotan (FL): CRC Press; 2016. p. 146–160.
   Google Scholar
• Mostafa DM, Ammar NM, Abd El-Alim SH, et al. Boswellia carterii liquisolid systems with promoted anti-inflammatory activity. Cdd. 2015;12:454–463.
   PubMed Web of Science ®Google Scholar
• Akinlade B, Elkordy AA, Essa EA, et al. Liquisolid systems to improve the dissolution of furosemide. Sci Pharm. 2010;78:325–344.
   PubMedGoogle Scholar
• Spireas S, Bolton SM. Inventors Liquisolid systems and methods of preparing same. U.S. A. patent US 6,096,337. 2000.
   Google Scholar
• Sankar R, Chung S, Perry MS, et al. Clinical considerations in transitioning patients with epilepsy from clonazepam to clobazam: a case series. J Med Case Reports. 2014;8:429.
   PubMedGoogle Scholar
• Kamble PR, Shaikh KS, Chaudhari PD. Application of liquisolid technology for enhancing solubility and dissolution of rosuvastatin. Adv Pharma Bullet 2014;4:197–204.
   PubMedGoogle Scholar
• Khames A. Liquisolid technique: a promising alternative to conventional coating for improvement of drug photostability in solid dosage forms. Exp Opin Drug Deliv. 2013;10:1335–1343.
   PubMed Web of Science ®Google Scholar
• Elkordy AA, Essa EA, Dhuppad S, et al. Liquisolid technique to enhance and to sustain griseofulvin dissolution: effect of choice of non-volatile liquid vehicles. Int J Pharm. 2012;434:122–132.
   PubMedGoogle Scholar
• Vemula SK, Veerareddy PR. Fast disintegrating tablets of flurbiprofen: formulation and characterization. Latin Amer J Pharm. 2011;30:1135–1141.
   Web of Science ®Google Scholar
• Khan KA. The concept of dissolution efficiency. J Pharm Pharmacol. 1975;27:48–49.
   PubMed Web of Science ®Google Scholar
• Bajaj S, Singla D, Sakhuja N. Stability Testing of Pharmaceutical Products. J Applied Pharm Sci. 2012;2:129–138.
   Google Scholar
• Costa P. An alternative method to the evaluation of similarity factor in dissolution testing. Int J Pharm. 2001;220:77–83.
   PubMed Web of Science ®Google Scholar
• Yokozawa T, Zheng PD, Oura H, et al. Animal model of adenine-induced chronic renal failure in rats. Nephron. 1986;44:230–234.
   PubMed Web of Science ®Google Scholar
• Kei S. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clinica Chimica Acta; Int J Clin Chem. 1978;90:37–43.
   PubMed Web of Science ®Google Scholar
• Koracevic D, Koracevic G, Djordjevic V. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol. 2001;54:356–361.
   PubMed Web of Science ®Google Scholar
• Aebi H. Catalase in vitro. Meth Enzymol. 1984;105:121–126
   PubMed Web of Science ®Google Scholar
• Stepaniak JA, Gould KE, Sun D, et al. A comparative study of experimental autoimmune encephalomyelitis in Lewis and DA rats. J Immunol. 1995;155:2762–2769.
   PubMed Web of Science ®Google Scholar
• Houot O. Creatinine. In: Siest G, Henny J, Schiele F, et al., editors. Interpretation of Clinical Laboratory Tests: reference Values and Their Biological Variation. Foster City (CA): Biomedical Publications; 1985. p. 220.
   Google Scholar
• Fawcett JK, Scott JE. A rapid and precise method for the determination of urea. J Clin Pathol. 1960;13:156–159.
   PubMed Web of Science ®Google Scholar
• Al-Okbi SY, Mohamed DA, Hamed TE, et al. Evaluation of the therapeutic effect of Nigella sativa crude oil and its blend with omega-3 fatty acid-rich oils in a modified hepatorenal syndrome model in rats. Grasas y Aceites. 2015;66:e103.
   Web of Science ®Google Scholar
• Abe LT, Lajolo FM, Genovese MI. Comparison of phenol content and antioxidant capacity of nuts. Ciênc Tecnol Aliment. 2010;30:254–259.
   Google Scholar
• Vranikova B, Gajdziok J. Liquisolid systems and aspects influencing their research and development. Acta Pharmaceutica. 2013;63:447–465.
   PubMed Web of Science ®Google Scholar
• Javadzadeh Y, Siahi-Shadbad MR, Barzegar-Jalali M, et al. Enhancement of dissolution rate of piroxicam using liquisolid compacts. Il Farmaco. 2005;60:361–365.
   PubMedGoogle Scholar
• Suliman AS, Anderson RJ, Elkordy AA. Norfloxacin as a model hydrophobic drug with unique release from liquisolid formulations prepared with PEG200 and Synperonic PE/L-61 non-volatile liquid vehicles. Powder Technol. 2014;257:156–167.
   Web of Science ®Google Scholar
• Tayel SA, Soliman II, Louis D. Improvement of dissolution properties of Carbamazepine through application of the liquisolid tablet technique. Europe J Pharm Biopharm. eV. 2008;69:342–347.
   PubMed Web of Science ®Google Scholar
• Nokhodchi A, Javadzadeh Y, Siahi-Shadbad MR, et al. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts. J Pharm Pharm Sci. 2005;8:18–25.
   PubMed Web of Science ®Google Scholar
• Nokhodchi A, Bolourtchian N, Dinarvand R. Dissolution and mechanical behaviors of recrystallized carbamazepine from alcohol solution in the presence of additives. J Cryst Growth. 2005;274:573–584.
   Web of Science ®Google Scholar
• Lu M, Xing H, Jiang J, et al. Liquisolid technique and its applications in pharmaceutics. Asian J Pharm Sci. 2017;12:115–123.
   Google Scholar
• Gavali SM, Pacharane SS, Sankpal SV, et al. Liquisolid compact: a new technique for enhancement of drug dissolution. Int J Res Pharm Chem 2011;1:705–713.
   Google Scholar
• Tiong N, Elkordy AA. Effects of liquisolid formulations on dissolution of naproxen. Europe J Pharm Biopharm. 2009;73:373–384.
   PubMed Web of Science ®Google Scholar
• Sarraguca MC, Cruz AV, Soares SO, et al. Determination of flow properties of pharmaceutical powders by near infrared spectroscopy. J Pharm Biomed Anal. 2010;52:484–492.
   PubMed Web of Science ®Google Scholar
• Padmapreetha J, Arulkumaran KSG. Improvement of dissolution rate of diacerein using liquisolid technique. J Chem Pharm Res 2016;8:209–219.
   Google Scholar
• Khan A, Agrawal S. Formulation and evaluation of lumefantrine capsule prepared by using liquisolid technique. Int J Curr Pharm Sci. 2018;10:43–50.
   Google Scholar
• Baranauskaite J, Kopustinskiene DM, Masteikova R, et al. Effect of liquid vehicles on the enhancement of rosmarinic acid and carvacrol release from oregano extract liquisolid compacts. Colloids Surf A. 2018;539:280–290.
   Google Scholar
• Gubbi S, Jarag R. Liquisolid technique for enhancement of dissolution properties of bromhexine hydrochloride. Research Journal of Pharmacy and Technology 2009;2:382–386.
   Google Scholar
• Javadzadeh Y, Shariati H, Movahhed-Danesh E, et al. Effect of some commercial grades of microcrystalline cellulose on flowability, compressibility, and dissolution profile of piroxicam liquisolid compacts. Drug Dev Ind Pharm. 2009;35:243–251.
   PubMed Web of Science ®Google Scholar
• Al-Okbi SY, Mohamed DA, Hamed TE, et al. Plant food extracts as a source of bioactive compounds for prevention of cisplatin-induced kidney dysfunction in rats. Polish J Food Nutri Sci. 2014;64:49–57.
   Web of Science ®Google Scholar
• Fouque D, Kalantar-Zadeh K, Kopple J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73:391–398.
   PubMed Web of Science ®Google Scholar
• Bonanni A, Mannucci I, Verzola D, et al. Protein-energy wasting and mortality in chronic kidney disease. Ijerph. 2011;8:1631–1654.
   Google Scholar
• Nguyen-Khoa T, Massy ZA, De Bandt JP, et al. Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment. Nephrol Dial Transpl. 2001;16:335–340.
   PubMed Web of Science ®Google Scholar
• Panichi V, Migliori M, De Pietro S, et al. C-reactive protein and interleukin-6 levels are related to renal function in predialytic chronic renal failure. Nephron. 2002;91:594–600.
   PubMed Web of Science ®Google Scholar
• Al-Okbi SY, Mohamed DA, Hamed TE, et al. Cereals' Products with Red Grape and Walnut Extracts as Functional Foods for Prevention of Kidney Dysfunction. Int J Biol Biomol Agricul Food Biotechnol Eng. 2013;7:583–590.
   Google Scholar
• Yokozawa T, Muto Y, Wakaki K, et al. Site of methylguanidine production and factors that influence production levels. Nephron. 2002;92:356–362.
   PubMed Web of Science ®Google Scholar